LemnaGene opens biomanufacturing facility
French biomanufacturing company LemnaGene, which uses the aquatic plant Spirodela from the Lemnaceae family, as its production platform, has opened a new laboratory and biomanufacturing facility in the incubation space for new projects, located at the Ecole normale superieure de Lyon (ENS Lyon).
French biomanufacturing company LemnaGene, which uses the aquatic plant Spirodela from the Lemnaceae family, as its production platform, has opened a new laboratory and biomanufacturing facility in the incubation space for new projects, located at the Ecole normale superieure de Lyon (ENS Lyon).
This will allow LemnaGene to provide a full range of biomanufacturing services to the pharmaceutical, vaccine, veterinarian, diagnostic, nutraceutical and industrial protein markets.
'This new facility is a big plus for us,' said Georges Freyssinet, ceo of LemnaGene. 'We can now produce efficiently transgenic Spirodela in a very nice environment. In addition, being inside the ENS Lyon allows us to work with high level scientific teams and have access to facilities and equipment that will speed up our development.'
LemnaGene was established in October 2003 with the support of US and French private investors and a e400,000 grant from the French Ministry of Research. The company has an exclusive license from the Weizmann Institute of Science, Israel, on know-how and patents developed by Weizmann scientists and has secured several additional licenses on enabling technologies. Agreements have been entered into with three development partners to validate the industrial feasibility of the LemnaGene platform for several genes of commercial interest.